$24.64
Price
$3.0B
Market Cap
14.4
P/E Ratio
9.5
Forward P/E
$1.71
EPS (TTM)
—
Dividend Yield
$690M
Cash
$3M
Total Debt
123M
Shares Out
$19.05
$26.58
52-Week Range
Institutional Ownership of CATALYST PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Fundsmith|Terry Smith
|
3.4M | $79M | $22.33 | +2.81% |
Trading Activity for CATALYST PHARMACEUTICALS INC
Insider Trading for CATALYST PHARMACEUTICALS INC
6 Months Insider Sentiment
Buy $0
Sell $3.4M
0
Buys
8
Sells
-3.4M
Net
1
Grants
Largest
$908K
Elsbernd
$609K
Elsbernd
$586K
Elsbernd
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 05, 2026 | Michael Wayne Kalb | Executive Vice President & CFO | EXERCISE | 7.1K | — | — |
| Jan 05, 2026 | Richard J Daly | President and CEO | EXERCISE | 42.1K | — | — |
| Dec 29, 2025 | David S Tierney | Director | EXERCISE | 1.3K | — | — |
| Dec 29, 2025 | Donald A Denkhaus | Director | EXERCISE | 1.3K | — | — |
| Dec 29, 2025 | Preethi Sundaram | Chief Strategy Officer | EXERCISE | 6.7K | — | — |
| Dec 29, 2025 | Patrick J Mcenany | Director | EXERCISE | 26.3K | — | — |
| Dec 29, 2025 | Molly Harper | Director | EXERCISE | 1.3K | — | — |
| Dec 29, 2025 | Steve Miller | Chief Op. & Scientific Officer | EXERCISE | 14.0K | — | — |
| Dec 29, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | EXERCISE | 6.7K | — | — |
| Dec 29, 2025 | Carmen Jeffrey Del | Chief Commercial Officer | EXERCISE | 8.7K | — | — |
| Dec 29, 2025 | Richard J Daly | President and CEO | EXERCISE | 1.3K | — | — |
| Dec 12, 2025 | Molly Harper | Director | SELL | 4.5K | $23.73 | $106K |
| Dec 12, 2025 | Molly Harper | Director | EXERCISE | 20.0K | $5.78 | $116K |
| Dec 12, 2025 | Molly Harper | Director | SELL | 6.7K | $23.06 | $156K |
| Dec 12, 2025 | Molly Harper | Director | SELL | 15.5K | $23.20 | $360K |
| Dec 08, 2025 | Tamar Thompson | Director | EXERCISE | 1.4K | — | — |
| Dec 08, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | EXERCISE | 7.1K | — | — |
| Dec 08, 2025 | Carmen Jeffrey Del | Chief Commercial Officer | EXERCISE | 8.0K | — | — |
| Dec 08, 2025 | David S Tierney | Director | EXERCISE | 1.4K | — | — |
| Dec 08, 2025 | Donald A Denkhaus | Director | EXERCISE | 1.4K | — | — |
| Dec 08, 2025 | Molly Harper | Director | EXERCISE | 1.4K | — | — |
| Dec 08, 2025 | Patrick J Mcenany | Director | EXERCISE | 3.5K | — | — |
| Dec 08, 2025 | Preethi Sundaram | Chief Strategy Officer | EXERCISE | 6.9K | — | — |
| Dec 08, 2025 | Steve Miller | Chief Op. & Scientific Officer | EXERCISE | 11.9K | — | — |
| Dec 01, 2025 | Patrick J Mcenany | Director | GRANT | 45.0K | — | — |
| Nov 26, 2025 | Carmen Jeffrey Del | Chief Commercial Officer | EXERCISE | 11.0K | $4.21 | $46K |
| Nov 26, 2025 | Carmen Jeffrey Del | Chief Commercial Officer | SELL | 11.0K | $23.33 | $256K |
| Nov 21, 2025 | Patrick J Mcenany | Director | EXERCISE | 1.8K | — | — |
| Nov 21, 2025 | Molly Harper | Director | EXERCISE | 947 | — | — |
| Nov 21, 2025 | Carmen Jeffrey Del | Chief Commercial Officer | EXERCISE | 5.6K | — | — |
| Nov 21, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | EXERCISE | 5.2K | — | — |
| Nov 21, 2025 | Preethi Sundaram | Chief Strategy Officer | EXERCISE | 5.6K | — | — |
| Nov 21, 2025 | Tamar Thompson | Director | EXERCISE | 947 | — | — |
| Nov 21, 2025 | Richard J Daly | President and CEO | EXERCISE | 20.0K | — | — |
| Nov 21, 2025 | Steve Miller | Chief Op. & Scientific Officer | EXERCISE | 8.3K | — | — |
| Nov 21, 2025 | Donald A Denkhaus | Director | EXERCISE | 947 | — | — |
| Nov 21, 2025 | Michael Wayne Kalb | Executive Vice President & CFO | EXERCISE | 6.9K | — | — |
| Nov 21, 2025 | David S Tierney | Director | EXERCISE | 947 | — | — |
| Nov 12, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | SELL | 40.0K | $22.70 | $908K |
| Sep 08, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | EXERCISE | 112.5K | $2.24 | $252K |
| Sep 08, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | SELL | 30.0K | $20.30 | $609K |
| Sep 04, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | SELL | 30.0K | $19.52 | $586K |
| Sep 04, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | EXERCISE | 30.0K | $2.24 | $67K |
| Sep 03, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | SELL | 20.0K | $20.08 | $402K |
| Sep 03, 2025 | Brian Elsbernd | Chief Compliance/Legal Officer | EXERCISE | 20.0K | $2.24 | $45K |